Resistance to fluoroquinolones (FQs) is relatively uncommon in Salmonella spp. when compared to other genera of the Enterobacteriaceae. However, the number of clinical isolates with reduced susceptibility to FQs has increased in recent years [1] . These isolates with reduced susceptibility to FQs are linked to chromosomal mutations and other mechanisms, such as efflux pump, change in permeability of the membrane, or plasmid-mediated quinolone resistance (PMQR) [2] .
To date, at least four types of PMQR genes are known, including the qnr genes (A, B, C, D, S, VC), the aac(6')-Ib-cr gene, oqxAB gene, and the qepA gene [2, 3] . Quinolones are used in poultry production, and poultry products are frequently related to salmonellosis outbreaks in Brazil. Nonetheless, it was unknown whether PMQR determinants were present in Salmonella strains isolated in outbreaks. The aim of this study was to investigate the presence of PMQR by qnr and aac(6´)-Ib genes in 126 Salmonella enterica strains isolated from poultry origin (n = 12), from patients (n = 46), and foods (n = 68) related to outbreaks that occurred between 1999 and 2007 in Parana state, Brazil.
The strains were obtained from the Central Laboratory of Parana (LACEN) Curitiba, Parana State, Brazil, and the serotyping and phagotyping were conducted at the Foundation Oswaldo Cruz (FIOCRUZ), Rio de Janeiro State, Brazil. The resistance to nalidixic acid (NAL) by disk diffusion tests, and minimum inhibitory concentration (MIC) by broth dilution for ciprofloxacin (CipMIC), were previously evaluated according to CLSI guidelines [4] .
A total of 112 (88.8%) isolates were resistant to nalidixic acid, and 29 (23.01%) showed reduced susceptibility to ciprofloxacin (MIC 0.125µg/ml or 0.5µg/ml) [1] . All the isolates were screened by PCR for PMQR determinants qnr (qnrA, qnrB1, qnrB5, qnrB19, qnrS1, qnrC, qnrD alleles and aac(6´)-Ib-cr gene) as described previously [5, 6] . The PCR products positive for qnr were sequenced and compared with the NCBI sequences.
The qnrA1 gene was detected in one epidemic strain of S. Enteritidis with CipMIC 0.062 ug/ml (GenBank accession number GU731067). The qnrB19 gene was detected in S. Corvallis of poultry origin with CipMIC of 0.5 ug/ml (GenBank accession number GU731069) ( Table 1 ). There are several reports of qnr genes detection in Salmonella strains susceptible to or with reduced susceptibility to ciprofloxacin [2, 5] . In Brazil, despite previous detection of qnrA1, qnrB2, qnrB8, qnrVC1, qnrVC2 genes in other bacterial species, as described by Minarini et al. [7] , this is the first report of the qnr gene in Salmonella, and also the first detection of the qnrB19 gene in this country.
The qnrB19 gene was recently detected in the Netherlands by Garcia-Fernandez et al. [8] in two strains of S. Typhimurium with reduced susceptibility to ciprofloxacin. Similarly, Dionisi et al. [9] detected, in Italy, a qnrB19 in S. Typhimurium with reduced susceptibility to ciprofloxacin. The S. Corvallis with a qnrB19 gene isolated in this study also had reduced susceptibility to ciprofloxacin. These results are significant because, as described in previous studies, the presence of PMQR genes may facilitate the development of mutations in the gyrA QRDR region, as well as increase the resistance to FQs and, consequently, reduce their clinical use [2, 3] .
Salmonellosis is one of the major foodborne illnesses in Brazil, and antibiotic therapy is required for treatment of systemic infections and/or for immunocompromised patients. The detection of qnr genes in Salmonella spp., and the identification in Brazil of the qnrB19 variant in a strain of poultry origin, alert for the control of quinolone use that is essential to avoid pressure for mutant selection of resistant strains and clinical limitation use of FQs. It is necessary to monitor and minimize the spread of such resistance determinants among these bacteria. 
